Sentinel Lymph Node Biopsy in Pelvic Tumors: Clinical Indications and Protocols Under Investigation

Marco Maccauro; Alice Lorenzoni; Flavio Crippa; Gianpiero Manca; Sotirios Chondrogiannis; Francesco Giammarile; Patrick M. Colletti; Gary J. Cook; Domenico Rubello

doi:10.1097/RLU.0000000000001184

Sentinel Lymph Node Biopsy in Pelvic Tumors: Clinical Indications and Protocols Under Investigation

Marco Maccauro, Alice Lorenzoni, Flavio Crippa, Gianpiero Manca, Sotirios Chondrogiannis, Francesco Giammarile, Patrick M. Colletti, Gary J. Cook, Domenico Rubello

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article

Abstract

ABSTRACT: Sentinel lymph node (SLN) sampling is an attractive alternative to complete lymphadenectomy. Based on the identification and sampling of the first LN draining a primary tumor, SLN biopsy is the most accurate and the only reliable method for microscopic nodal staging for solid tumors including breast cancer and melanoma. Lymph node status in pelvic tumors remains the most important prognostic factor for recurrence and survival and a major decision criterion for adjuvant therapy. We review the clinical indications, controversies, and perspective of SLN biopsy in male and female pelvic cancers.

Original language	English
Journal	Clinical Nuclear Medicine
DOIs	https://doi.org/10.1097/RLU.0000000000001184
Publication status	Accepted/In press - Feb 24 2016

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1097/RLU.0000000000001184

Fingerprint Dive into the research topics of 'Sentinel Lymph Node Biopsy in Pelvic Tumors: Clinical Indications and Protocols Under Investigation'. Together they form a unique fingerprint.

Cite this

Maccauro, M., Lorenzoni, A., Crippa, F., Manca, G., Chondrogiannis, S., Giammarile, F., Colletti, P. M., Cook, G. J., & Rubello, D. (Accepted/In press). Sentinel Lymph Node Biopsy in Pelvic Tumors: Clinical Indications and Protocols Under Investigation. Clinical Nuclear Medicine. https://doi.org/10.1097/RLU.0000000000001184

Sentinel Lymph Node Biopsy in Pelvic Tumors : Clinical Indications and Protocols Under Investigation. / Maccauro, Marco ; Lorenzoni, Alice; Crippa, Flavio; Manca, Gianpiero; Chondrogiannis, Sotirios; Giammarile, Francesco; Colletti, Patrick M.; Cook, Gary J.; Rubello, Domenico.

In: Clinical Nuclear Medicine, 24.02.2016.

Research output: Contribution to journal › Article

@article{3e1e831ebfd04ea4aa719e606b30b649,

title = "Sentinel Lymph Node Biopsy in Pelvic Tumors: Clinical Indications and Protocols Under Investigation",

abstract = "ABSTRACT: Sentinel lymph node (SLN) sampling is an attractive alternative to complete lymphadenectomy. Based on the identification and sampling of the first LN draining a primary tumor, SLN biopsy is the most accurate and the only reliable method for microscopic nodal staging for solid tumors including breast cancer and melanoma. Lymph node status in pelvic tumors remains the most important prognostic factor for recurrence and survival and a major decision criterion for adjuvant therapy. We review the clinical indications, controversies, and perspective of SLN biopsy in male and female pelvic cancers.",

author = "Marco Maccauro and Alice Lorenzoni and Flavio Crippa and Gianpiero Manca and Sotirios Chondrogiannis and Francesco Giammarile and Colletti, {Patrick M.} and Cook, {Gary J.} and Domenico Rubello",

year = "2016",

month = feb,

day = "24",

doi = "10.1097/RLU.0000000000001184",

language = "English",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Sentinel Lymph Node Biopsy in Pelvic Tumors

T2 - Clinical Indications and Protocols Under Investigation

AU - Maccauro, Marco

AU - Lorenzoni, Alice

AU - Crippa, Flavio

AU - Manca, Gianpiero

AU - Chondrogiannis, Sotirios

AU - Giammarile, Francesco

AU - Colletti, Patrick M.

AU - Cook, Gary J.

AU - Rubello, Domenico

PY - 2016/2/24

Y1 - 2016/2/24

N2 - ABSTRACT: Sentinel lymph node (SLN) sampling is an attractive alternative to complete lymphadenectomy. Based on the identification and sampling of the first LN draining a primary tumor, SLN biopsy is the most accurate and the only reliable method for microscopic nodal staging for solid tumors including breast cancer and melanoma. Lymph node status in pelvic tumors remains the most important prognostic factor for recurrence and survival and a major decision criterion for adjuvant therapy. We review the clinical indications, controversies, and perspective of SLN biopsy in male and female pelvic cancers.

AB - ABSTRACT: Sentinel lymph node (SLN) sampling is an attractive alternative to complete lymphadenectomy. Based on the identification and sampling of the first LN draining a primary tumor, SLN biopsy is the most accurate and the only reliable method for microscopic nodal staging for solid tumors including breast cancer and melanoma. Lymph node status in pelvic tumors remains the most important prognostic factor for recurrence and survival and a major decision criterion for adjuvant therapy. We review the clinical indications, controversies, and perspective of SLN biopsy in male and female pelvic cancers.

UR - http://www.scopus.com/inward/record.url?scp=84959098675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959098675&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000001184

DO - 10.1097/RLU.0000000000001184

M3 - Article

AN - SCOPUS:84959098675

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

ER -